ATE321867T1 - Zusammensetzungen und methoden zur verwendung von dna polymerasen - Google Patents

Zusammensetzungen und methoden zur verwendung von dna polymerasen

Info

Publication number
ATE321867T1
ATE321867T1 AT00973960T AT00973960T ATE321867T1 AT E321867 T1 ATE321867 T1 AT E321867T1 AT 00973960 T AT00973960 T AT 00973960T AT 00973960 T AT00973960 T AT 00973960T AT E321867 T1 ATE321867 T1 AT E321867T1
Authority
AT
Austria
Prior art keywords
compositions
methods
polymerase
dna polymerases
mutant
Prior art date
Application number
AT00973960T
Other languages
English (en)
Inventor
Joseph A Sorge
Holly H Hogrefe
Connie J Hansen
Original Assignee
Stratagene California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stratagene California filed Critical Stratagene California
Application granted granted Critical
Publication of ATE321867T1 publication Critical patent/ATE321867T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1252—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mathematical Physics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Theoretical Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT00973960T 1999-10-29 2000-10-27 Zusammensetzungen und methoden zur verwendung von dna polymerasen ATE321867T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16260099P 1999-10-29 1999-10-29

Publications (1)

Publication Number Publication Date
ATE321867T1 true ATE321867T1 (de) 2006-04-15

Family

ID=22586340

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00973960T ATE321867T1 (de) 1999-10-29 2000-10-27 Zusammensetzungen und methoden zur verwendung von dna polymerasen

Country Status (7)

Country Link
US (2) US6946273B1 (de)
EP (1) EP1226255B1 (de)
JP (1) JP4949585B2 (de)
AT (1) ATE321867T1 (de)
AU (1) AU1239901A (de)
DE (1) DE60027040T2 (de)
WO (1) WO2001032887A1 (de)

Families Citing this family (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8268605B2 (en) 1999-10-29 2012-09-18 Agilent Technologies, Inc. Compositions and methods utilizing DNA polymerases
US20040009486A1 (en) * 1999-10-29 2004-01-15 Sorge Joseph A. Compositions and methods utilizing DNA polymerases
US20030228616A1 (en) * 1999-10-29 2003-12-11 Stratagene DNA polymerase mutants with reverse transcriptase activity
US20050123940A1 (en) * 1999-10-29 2005-06-09 Stratagene California Compositions and methods for synthesizing cDNA
US20030180741A1 (en) 2001-12-21 2003-09-25 Holly Hogrefe High fidelity DNA polymerase compositions and uses therefor
US6803201B2 (en) * 2002-01-24 2004-10-12 Stratagene Compositions and methods for polynucleotide sequence determination
WO2004038007A2 (en) * 2002-10-25 2004-05-06 Stratagene Dna polymerases with reduced base analog detection activity
US8283148B2 (en) 2002-10-25 2012-10-09 Agilent Technologies, Inc. DNA polymerase compositions for quantitative PCR and methods thereof
US7960157B2 (en) 2002-12-20 2011-06-14 Agilent Technologies, Inc. DNA polymerase blends and uses thereof
AU2004225520A1 (en) 2003-03-25 2004-10-14 Stratagene DNA polymerase fusions and uses thereof
GB0321306D0 (en) 2003-09-11 2003-10-15 Solexa Ltd Modified polymerases for improved incorporation of nucleotide analogues
GB0324456D0 (en) * 2003-10-20 2003-11-19 Isis Innovation Parallel DNA sequencing methods
US20100216153A1 (en) 2004-02-27 2010-08-26 Helicos Biosciences Corporation Methods for detecting fetal nucleic acids and diagnosing fetal abnormalities
CA2568998A1 (en) 2004-06-04 2005-12-15 Takara Bio Inc. Polypeptides having dna polymerase activity
EP1888743B1 (de) 2005-05-10 2011-08-03 Illumina Cambridge Limited Verbesserte polymerasen
KR100757280B1 (ko) 2005-11-01 2007-09-11 한국해양연구원 고호열성 신균주 ｋｃｔｃ 10859ｂｐ 및 이로부터 생산되는고호열성 아밀라아제
EP1914303A1 (de) * 2006-10-09 2008-04-23 Qiagen GmbH Thermus eggertssonii DNA Polymerasen
KR100777230B1 (ko) * 2006-11-30 2007-11-28 한국해양연구원 써모코커스 유래 돌연변이 ｄｎａ 중합효소들 및 그의유전자들
US9085762B2 (en) * 2006-12-29 2015-07-21 Agilent Technologies, Inc. Compositions and methods using split polymerases
US20090137405A1 (en) * 2007-11-16 2009-05-28 Christopher Bowman Detection of nucleic acid biomarkers using polymerization-based amplification
US7682809B2 (en) 2008-01-11 2010-03-23 Agilent Technologies, Inc. Direct ATP release sequencing
EP2644708B1 (de) 2008-04-30 2014-12-17 Integrated Dna Technologies, Inc. Rnase-h-basierte assays unter verwendung von modifizierten rna monomeren
US10227641B2 (en) 2008-04-30 2019-03-12 Integrated Dna Technologies, Inc. RNase H-based assays utilizing modified RNA monomers
CA2742593C (en) 2008-11-03 2020-05-05 Kapa Biosystems, Inc. Chimeric dna polymerases
WO2010068680A1 (en) 2008-12-10 2010-06-17 Mount Sinai School Of Medicine Of New York University Thelper cell type 17 lineage-specific adjuvants, compositions and methods
EP2478373B1 (de) 2009-09-14 2019-01-09 Icahn School of Medicine at Mount Sinai Verfahren zur charakterisierung der antikörperbindungsaffinität und der epitopdiversität bei lebensmittelallergien
US8715987B2 (en) 2011-05-02 2014-05-06 New England Biolabs, Inc. Solubilized phospholipids for stabilizing nucleic acid polymerases
US8921043B2 (en) 2011-05-11 2014-12-30 New England Biolabs, Inc. DNA polymerase variants with reduced exonuclease activity and uses thereof
US8921044B2 (en) 2011-05-11 2014-12-30 New England Biolabs, Inc. DNA polymerase variants with reduced exonuclease activity and uses thereof
US20140235474A1 (en) 2011-06-24 2014-08-21 Sequenom, Inc. Methods and processes for non invasive assessment of a genetic variation
US9367663B2 (en) 2011-10-06 2016-06-14 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US10424394B2 (en) 2011-10-06 2019-09-24 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9984198B2 (en) 2011-10-06 2018-05-29 Sequenom, Inc. Reducing sequence read count error in assessment of complex genetic variations
WO2013052907A2 (en) 2011-10-06 2013-04-11 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US10196681B2 (en) 2011-10-06 2019-02-05 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
CA2861856C (en) 2012-01-20 2020-06-02 Sequenom, Inc. Diagnostic processes that factor experimental conditions
US10504613B2 (en) 2012-12-20 2019-12-10 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9920361B2 (en) 2012-05-21 2018-03-20 Sequenom, Inc. Methods and compositions for analyzing nucleic acid
JP6450308B2 (ja) 2012-06-14 2019-01-09 ライフ テクノロジーズ コーポレーション ポリメラーゼ連鎖反応（ｐｃｒ）のための新規の組成物、方法、およびキット
US10497461B2 (en) 2012-06-22 2019-12-03 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
JP6478444B2 (ja) 2012-09-28 2019-03-06 東洋紡株式会社 改変された耐熱性ｄｎａポリメラーゼ
US10482994B2 (en) 2012-10-04 2019-11-19 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US20130309666A1 (en) 2013-01-25 2013-11-21 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US10930368B2 (en) 2013-04-03 2021-02-23 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
KR102665592B1 (ko) 2013-05-24 2024-05-21 시쿼넘, 인코포레이티드 유전적 변이의 비침습 평가를 위한 방법 및 프로세스
ES3037160T3 (en) 2013-06-21 2025-09-29 Sequenom Inc Methods and processes for non-invasive assessment of genetic variations
HRP20200250T1 (hr) 2013-08-08 2020-05-29 The Scripps Research Institute Metoda site-specifično enzimsko obilježavanje nukleinskih kiselina in vitro ugradnjom neprirodnih nukleotida
KR102384620B1 (ko) 2013-10-04 2022-04-11 시쿼넘, 인코포레이티드 유전적 변이의 비침습 평가를 위한 방법 및 프로세스
CN105874082B (zh) 2013-10-07 2020-06-02 塞昆纳姆股份有限公司 用于非侵入性评估染色体改变的方法和过程
JP2016536995A (ja) 2013-11-14 2016-12-01 インテグレイテツド・デイー・エヌ・エイ・テクノロジーズ・インコーポレイテツド 増大した鋳型識別活性を有するｄｎａポリメラーゼ突然変異体
TWI638047B (zh) 2014-04-09 2018-10-11 史基普研究協會 藉由核酸三磷酸酯轉運子將非天然或經修飾的核苷三磷酸酯輸入至細胞中
US11783911B2 (en) 2014-07-30 2023-10-10 Sequenom, Inc Methods and processes for non-invasive assessment of genetic variations
US10329545B2 (en) 2014-11-14 2019-06-25 Illumina, Inc. Polymerases
US20200231947A1 (en) * 2015-09-09 2020-07-23 Qiagen Gmbh Polymerase enzyme
WO2017106767A1 (en) 2015-12-18 2017-06-22 The Scripps Research Institute Production of unnatural nucleotides using a crispr/cas9 system
WO2017121836A1 (en) 2016-01-15 2017-07-20 Thermo Fisher Scientific Baltics Uab Thermophilic dna polymerase mutants
CN108699539B (zh) * 2016-02-29 2022-11-18 吉尼亚科技公司 外切核酸酶缺陷的聚合酶
US20190176153A1 (en) 2016-05-18 2019-06-13 Roche Sequencing Solutions, Inc. Quantitative real time pcr amplification using an electrowetting-based device
ES2898088T3 (es) 2016-06-01 2022-03-03 Hoffmann La Roche Inmuno-PETE
US20190218257A1 (en) 2016-06-24 2019-07-18 The Scripps Research Institute Novel nucleoside triphosphate transporter and uses thereof
US10907204B2 (en) 2016-07-12 2021-02-02 Roche Sequencing Solutions, Inc. Primer extension target enrichment
CA3030890A1 (en) 2016-07-27 2018-02-01 Sequenom, Inc. Genetic copy number alteration classifications
CA3207879A1 (en) 2017-01-24 2018-08-02 Sequenom, Inc. Methods and processes for assessment of genetic variations
EP3580351A1 (de) * 2017-02-13 2019-12-18 Qiagen Sciences, LLC Polymeraseenzym aus 9°n
WO2018162538A1 (en) 2017-03-08 2018-09-13 F. Hoffmann-La Roche Ag Primer extension target enrichment and improvements thereto including simultaneous enrichment of dna and rna
US12297491B2 (en) 2017-03-08 2025-05-13 Roche Sequencing Solutions, Inc. Primer extension target enrichment and improvements thereto including simultaneous enrichment of DNA and RNA
JP7370862B2 (ja) 2017-03-17 2023-10-30 セクエノム， インコーポレイテッド 遺伝子モザイク症のための方法およびプロセス
WO2018191857A1 (zh) * 2017-04-18 2018-10-25 深圳华大智造科技有限公司 Phi29 DNA聚合酶及其编码基因与应用
EP3645710A1 (de) 2017-06-26 2020-05-06 Thermo Fisher Scientific Baltics Uab Thermophile dna-polymerase-mutanten
WO2019014262A1 (en) 2017-07-11 2019-01-17 The Scripps Research Institute INCORPORATION OF NON-NATURAL NUCLEOTIDES AND METHODS OF IN VIVO USE THEREOF
JP7325341B2 (ja) 2017-07-11 2023-08-14 シンソークス，インク． 非天然ヌクレオチドの組み込み及びその方法
KR20240141853A (ko) 2017-08-03 2024-09-27 신톡스, 인크. 자가면역 질환의 치료를 위한 사이토카인 접합체
SG11202006101WA (en) 2017-12-29 2020-07-29 Scripps Research Inst Unnatural base pair compositions and methods of use
EP3874036A1 (de) 2018-10-31 2021-09-08 Illumina, Inc. Polymerasen, zusammensetzungen und verfahren zur verwendung
WO2020117968A2 (en) 2018-12-05 2020-06-11 Illumina, Inc. Polymerases, compositions, and methods of use
EP3923974A4 (de) 2019-02-06 2023-02-08 Synthorx, Inc. Il-2-konjugate und verfahren zur verwendung davon
AU2020291535A1 (en) 2019-06-14 2022-01-20 The Scripps Research Institute Reagents and methods for replication, transcription, and translation in semi-synthetic organisms
JP7323703B2 (ja) 2019-08-19 2023-08-08 エフ． ホフマン－ラ ロシュ アーゲー 配列決定用のｄｎａ及びｒｎａのシングルチューブ調製
WO2021053008A1 (en) 2019-09-20 2021-03-25 F. Hoffmann-La Roche Ag Immune repertoire profiling by primer extension target enrichment
EP4055155A1 (de) * 2019-11-08 2022-09-14 Pacific Biosciences of California, Inc. Modifizierte polymerasen zur verbesserten sequenzierung durch bindung
US11591629B2 (en) * 2019-12-23 2023-02-28 Cheng-Yao Chen Method and kit for template-independent nucleic acid synthesis
US12590328B2 (en) 2020-07-08 2026-03-31 Roche Sequencing Solutions, Inc. Targeted depletion of non-target library molecules using poison primers during target capture of next-generation sequencing libraries
US12378596B2 (en) 2020-12-03 2025-08-05 Roche Sequencing Solutions, Inc. Whole transcriptome analysis in single cells
KR20230124946A (ko) 2020-12-24 2023-08-28 인티그레이티드 디엔에이 테크놀로지스 아이엔씨. 고-충실도 DNA 폴리머라아제를 이용한 rhPCR 기반 앰플리콘시퀀싱에서 프라이머 이량체 및 오프-타겟 증폭을 감소시키는 RNAse H2 돌연변이체
CN112779238B (zh) * 2020-12-28 2024-01-30 广州达安基因股份有限公司 用于丙肝病毒检测的dna聚合酶混合物
EP4294941B1 (de) 2021-02-18 2025-03-26 F. Hoffmann-La Roche AG Struktur zur verhinderung des einfädelns von nukleinsäuretemplates durch eine nanopore während der sequenzierung
EP4308723B1 (de) 2021-03-15 2025-04-23 F. Hoffmann-La Roche AG Gezielte sequenzierung der nächsten generation über verankerte primerextension
US20240158839A1 (en) 2021-03-15 2024-05-16 President And Fellows Of Harvard College Methods for in situ sequencing
WO2022207682A1 (en) 2021-04-01 2022-10-06 F. Hoffmann-La Roche Ag Immune cell counting of sars-cov-2 patients based on immune repertoire sequencing
US12077789B2 (en) 2021-08-14 2024-09-03 Illumina, Inc. Polymerases, compositions, and methods of use
TWI869710B (zh) * 2021-09-29 2025-01-11 呈堯 陳 用於無模板ｒｎａ合成的核酸聚合酶變體、試劑套組及方法
CN114015672B (zh) * 2021-12-06 2022-05-31 江南大学 一种Pfu DNA聚合酶
US11788075B2 (en) * 2022-02-18 2023-10-17 Element Biosciences, Inc. Engineered polymerases with reduced sequence-specific errors
EP4547839A1 (de) 2022-06-30 2025-05-07 Kapa Biosystems, Inc. Steuerung der tagmentationssequenzierungsbibliothekseinsatzgrösse unter verwendung histonähnlicher proteine in der archae
CN121241132A (zh) * 2023-06-02 2025-12-30 武汉华大智造科技有限公司 用于测序的dna聚合酶突变体
CN121605113A (zh) 2023-06-14 2026-03-03 豪夫迈·罗氏有限公司 5-甲酰基胞嘧啶的加速标记及在核酸甲基化测序中的应用
WO2025024676A1 (en) 2023-07-26 2025-01-30 Caribou Biosciences, Inc. In vitro validation methods for cd19-targeting cell therapies
WO2025193609A1 (en) 2024-03-11 2025-09-18 Caribou Biosciences, Inc. Methods and compositions for cost-effective assessment of nucleic acid transcripts and isoforms in cells
WO2025207517A2 (en) 2024-03-25 2025-10-02 Synthorx, Inc. Synthetic trna synthetases and cells comprising synthetic molecules for production of polypeptides
WO2025210056A1 (en) 2024-04-03 2025-10-09 Roche Sequencing Solutions, Inc. In vitro amplification of dna methylation patterns
WO2025240460A2 (en) 2024-05-14 2025-11-20 Roche Molecular Systems, Inc. Assay for detection of mutations conferring resistance to treatment with an immunotherapeutic agent
WO2026082489A1 (en) 2024-10-18 2026-04-23 F. Hoffmann-La Roche Ag Universal pcr to boost molecule recovery in cell free dna library preparation and target enrichment workflows

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674679A (en) 1991-09-27 1997-10-07 Amersham Life Science, Inc. DNA cycle sequencing
US5547859A (en) * 1993-08-02 1996-08-20 Goodman; Myron F. Chain-terminating nucleotides for DNA sequencing methods
ATE143057T1 (de) 1994-10-17 1996-10-15 Harvard College Dns polymerase mit veränderter nukleotid- bindungstelle
US5614365A (en) 1994-10-17 1997-03-25 President & Fellow Of Harvard College DNA polymerase having modified nucleotide binding site for DNA sequencing
US5885813A (en) * 1995-05-31 1999-03-23 Amersham Life Science, Inc. Thermostable DNA polymerases
WO1997039150A1 (en) * 1996-04-15 1997-10-23 University Of Southern California Synthesis of fluorophore-labeled dna
US5882904A (en) * 1997-08-04 1999-03-16 Amersham Pharmacia Biotech Inc. Thermococcus barossii DNA polymerase mutants

Also Published As

Publication number Publication date
DE60027040D1 (de) 2006-05-18
EP1226255A1 (de) 2002-07-31
JP2004500052A (ja) 2004-01-08
JP4949585B2 (ja) 2012-06-13
AU1239901A (en) 2001-05-14
US20050158730A1 (en) 2005-07-21
WO2001032887A1 (en) 2001-05-10
US6946273B1 (en) 2005-09-20
DE60027040T2 (de) 2006-11-23
EP1226255B1 (de) 2006-03-29

Similar Documents

Publication Publication Date Title
ATE321867T1 (de) Zusammensetzungen und methoden zur verwendung von dna polymerasen
WO2003054139A3 (en) Compositions and methods utilizing dna polymerases
BG100188A (bg) Ензими за секвениране на днк
EP2272952B8 (de) Thermostabiler oder thermoactiver DNA-polymerase mit abgeschwächter 3'-5' Exonukleaseaktivität
DE69534855D1 (de) Enzymaktive dna moleküle
WO2001094562A3 (en) Cold sensitive mutant dna polymerases
WO2001051006A3 (en) Cardiac-cell specific enhancer elements and uses thereof
ATE181106T1 (de) Mutationen in der 5'-3'-exonukleaseaktivität thermostabiler dna-polymerasen
ATE380883T1 (de) Direkte multiplex charakterisierung von genomischer dna
WO1995014782A3 (en) A modified thermo resistant dna polymerase
MXPA02012256A (es) Proteinas v de morbillivirus modificados.
DE69531660D1 (de) Klonierte dna polymerasen aus thermotoga neapolitana und resultierende mutanten
ES2162132T3 (es) Polimerasa de adn termoestable procedente de thermoanaerobacter thermohydrosulfuricus y enzimas mutantes, de actividad exonucleasa suprimida asi obtenidos.
DE69133629D1 (de) nssystem zur Bestimmung von genetischen Krankheiten
DE60110564D1 (en) Rna polymerase mutanten mit erhöhter thermostabilität
ATE371022T1 (de) Fy7 polymerase
EP1064296A4 (de) Temperaturstabile dna polymerase aus thermoanaerobacter thermohydrosulfuricus
WO2004038007A3 (en) Dna polymerases with reduced base analog detection activity
ATE277171T1 (de) Ikk-alpha proteine, nukleinsäuren und verfahren
WO2002020735A3 (en) Enzymes having high temperature polymerase activity and methods of use thereof
AU1070002A (en) Materials and methods relating to nucleic acid amplification and profiling
EP0810288A3 (de) Neue DNA-Polymerase mit 3'-5' Proofreading Exonuklease Atkivität zur Korrekturlesung
EP2314596A3 (de) DNA-Polymerase-mischungen und mutante DNA-polymerasen
WO2000012716A3 (en) MAIZE Ku70 ORTHOLOGUE AND USES THEREOF
WO1998003662A3 (en) Drosophila melanogaster p70 s6 kinase

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties